Effects of Sperm Treatment on the Anti-sperm Antibodies IgG and IgA
International Journal of Immunology
Volume 5, Issue 3, June 2017, Pages: 49-52
Received: May 31, 2017; Accepted: Jun. 12, 2017; Published: Jul. 17, 2017
Views 1782      Downloads 102
Authors
Lheureux Helene, Assisted Medical Procreation Center, University Center Hospital South Réunion, Réunion Island, France
Randriamahazo Rakotomalala Toky, Assisted Medical Procreation Center, University Center Hospital South Réunion, Réunion Island, France
Mons Joffrey, Assisted Medical Procreation Center, University Center Hospital South Réunion, Réunion Island, France
Gabriele Marc, Assisted Medical Procreation Center, University Center Hospital South Réunion, Réunion Island, France
Article Tools
Follow on us
Abstract
Anti-sperm antibodies (ASA) form a class of glycoproteins commonly found in infertile men. This class of antibody causes an impairment of the spermatozoon's ability to cross cervical mucus and interact with the oocyte. The aim of our study was to analyze clinical and biological parameters of the sperm among positive ASA patients seen at the Center of Assisted Medical Procreation of the CHU Reunion before and after in-vitro treatment of autoimmune sperms. During the period from April 01, 2013 to February 29, 2015, we analyzed clinico-biological parameters of patients coming for exploring an infertility state with ASA IgG and IgA research before and after sperm treatment. Fourteen (1.51%) patients had a positive ASA, with a combination of ASA IgG and IgA for 71.42% of them. After in vitro treatment of the autoimmune sperm we found a persistence of IgA in 21.43% without IgG.
Keywords
Anti-Sperm Antibodies, Sperm Treatment, Réunion Island
To cite this article
Lheureux Helene, Randriamahazo Rakotomalala Toky, Mons Joffrey, Gabriele Marc, Effects of Sperm Treatment on the Anti-sperm Antibodies IgG and IgA, International Journal of Immunology. Vol. 5, No. 3, 2017, pp. 49-52. doi: 10.11648/j.iji.20170503.12
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
World Health Organization. World Health Organization manualfor the standardised investigation and diagnosis of the infertilecouple. Cambridge: Cambridge University Press; 2000.
[2]
Nakabayashi, N. T., Tyler, E. T., & Tyler, A. (1961). Immunologic aspects of human infertility. Fertility and sterility, 12(6), 544-50.
[3]
Meinertz H, Linnet L, Fogh-Andersen P, et al. Antisperm anti-bodies and fertility after vasovasostomy: a follow-up study of216 men. FertilSteril 1990; 54: 315—21.
[4]
World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 5th ed. Geneva 2010.
[5]
Blanc B, Boubli L. Infertilité du couple. Gynécologie. Paris: ÉditionPradel; 2003.
[6]
Merzndar S, Levine S. Antisperm antibodies: etiology, pathogenesis, diagnosis and treatment. FertilSteril 1998; 70: 799—810.
[7]
Marconi M, Nowotny A, Pantke P. Antisperm antibodies detec-ted by mixed agglutination reaction and immunobead test arenot associated with chronic inflammation and infection of semi-nal tract. Andrology 2008; 40: 227—34.
[8]
Wolff H, Polich JA, Martinez A, Haimovici F, Hill JA, AndersonDJ. Leukocytospermia is associated with poor semen quality. FertilSteril 1990; 53: 528—36.
[9]
Lenzi, et al. Unilateral cryptorchidism corrected in prepubertalage: evaluation of sperm parameters, hormones and antispermantibodies in adult age. FertilSteril 1997; 5: 943—8.
[10]
Gilbert BR, Witkim SS, Goldstein M. Correlation of sperm-boundimmunoglobulins with impaired semen analysis in infertile menwithvaricoceles. Fertil Steril 1989; 52: 469—73.
[11]
Barthélémy C. Indications de la recherche des anticorps anti-spermatozoïdes. Andrologie 2003; 13(1): 70—80.
[12]
De Muylder X, et al. La stérilité d’origine immunologique. CanMed Assoc J 2002; 130: 591—602.
[13]
Jager S, Kremer J, Kuiken J, Mulder I. The significance ofthe Fc part of anti spermatozoal antibodies for the shaking.
[14]
Meinertz H, Linnet L, Fogh-Andersen P, et al. Antisperm anti-bodies and fertility after vasovasostomy: a follow-up study of216 men. FertilSteril 1990; 54: 315—21.
[15]
Check JH, Hourani W, Check ML, Graziano V, Levin E. Effectof treating antibody-coated sperm with chymotrypsin on pre-gnancy rates following IUI as compared to outcome of IVF/ICSI. ArchAndrol 2004; 50: 93—5.
[16]
Ombelet W, Vandeput H, Janssen M, Cox A, Vossen C, PolletH, et al. Treatment of male infertility due to sperm surfaceantibodies: IUI or IVF? Hum Reprod 1997; 12(6): 1167—70.
[17]
Naggy, et al. Results of 55 intracytoplasmic sperm injectioncycles in the treatment of male immunological infertility. HumReprod 1995; 10: 1775—80.
[18]
Mahmoud A, Comhaire F. Antisperm antibodies: use of themixed agglutination reaction (MAR) test using latex beads. HumReprod 2000; 15: 231—3.
[19]
Francavilla F et al. (1992): Failure of intrauterine insemination in male immunological infertility in cases which all spermatozoa are antibody-coated. FertilSteril 58: 587–592.
[20]
Hjort T, Meinertz H (1988) Antisperm antibodies and immune subfertility. Hum Reprod3, 59-67.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186